PEP trial. Pulmonary Embolism Prevention.
Parker
M
M
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D006620:Hip Fractures / Q000601:surgery; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000209:etiology; D011655:Pulmonary Embolism / Q000517:prevention & control*; D015996:Survival Rate; D013923:Thromboembolism / Q000517:prevention & control; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin